Holoprosencephaly (HPE) is a common malformation of the developing forebrain and midface characterized by incomplete penetrance and variable expressivity. Familial HPE has been reported in many families with autosomal dominant inheritance in some and apparent autosomal recessive inheritance in others. We have examined 125 individuals from nine families with autosomal dominant HPE. Expression in gene carriers varied from alobar HPE and cyclopia through microforms such as microcephaly or single central incisor to normal phenotype. We performed linkage studies by either Southern blot or polymerase chain reaction analyses with DNA markers (D7S22, D7S550, and D7S483) that are deleted from some patients with sporadic HPE and flank a translocation breakpoint in 7q36 associated with HPE. The strongest support for linkage was with D7S22, which was linked with no recombination to autosomal dominant HPE in eight of nine families with a combined logarithm of odds score of 6.4 with an affecteds-only model-free analysis and 8.2 with a reducedpenetrance model and all phenotypes. Close linkage to this region could be excluded in one family, and there was significant evidence of genetic heterogeneity. These results show that a gene for autosomal dominant HPE is located in a chromosomal region (7q36) known to be involved in sporadic HPE with visible cytogenetic deletions. They also demonstrate genetic heterogeneity in familial HPE. We hypothesize that mutations of a gene in 7q36, designated HPE3, are responsible for both sporadic HPE and a majority of families with autosomal dominant HPE.
ABSTRACT
Holoprosencephaly (HPE) is a common malformation of the developing forebrain and midface characterized by incomplete penetrance and variable expressivity. Familial HPE has been reported in many families with autosomal dominant inheritance in some and apparent autosomal recessive inheritance in others. We have examined 125 individuals from nine families with autosomal dominant HPE. Expression in gene carriers varied from alobar HPE and cyclopia through microforms such as microcephaly or single central incisor to normal phenotype. We performed linkage studies by either Southern blot or polymerase chain reaction analyses with DNA markers (D7S22, D7S550, and D7S483) that are deleted from some patients with sporadic HPE and flank a translocation breakpoint in 7q36 associated with HPE. The strongest support for linkage was with D7S22, which was linked with no recombination to autosomal dominant HPE in eight of nine families with a combined logarithm of odds score of 6.4 with an affecteds-only model-free analysis and 8.2 with a reducedpenetrance model and all phenotypes. Close linkage to this region could be excluded in one family, and there was significant evidence of genetic heterogeneity. These results show that a gene for autosomal dominant HPE is located in a chromosomal region (7q36) known to be involved in sporadic HPE with visible cytogenetic deletions. They also demonstrate genetic heterogeneity in familial HPE. We hypothesize that mutations of a gene in 7q36, designated HPE3, are responsible for both sporadic HPE and a majority of families with autosomal dominant HPE.
Holoprosencephaly (HPE) is a complex malformation manifested by failure of cleavage of the developing forebrain and associated defects of the midface. It designates a series of brain and face malformations of graded severity that begins with alobar HPE and cyclopia and extends in unbroken sequence through several intermediate forms to a normal brain and face (1, 2) . HPE has an estimated incidence of 1 in 16,000 live births and is more common in early gestation with an incidence of 1 in 250 induced abortions (3).
Significant causal heterogeneity has been demonstrated for HPE. It has been associated with several different teratogens such as maternal diabetes (4), although genetic causes are probably more common. It occurs frequently in aneuploidy syndromes, especially trisomies 13 and 18. HPE has been associated also with several nonrandom structural chromosome anomalies including del(2)(p21), dup(3pter), del(7)(q36), del(18p), and del(21)(q22.3). We hypothesized previously that these chromosome regions contain genes important for normal development of the brain and face (2, 5 As part of our studies of the genetic causes of HPE, we identified nine families with AD HPE, four of which have been reported (8) (9) (10) (11) . We hypothesized that the gene or genes involved in familial HPE were the same as those involved with the nonrandom structural chromosome anomalies and selected these regions for study. Here we report linkage of AD HPE in eight of nine families to 7q36.
MATERIALS AND METHODS
Phenotype Evaluation. We identified nine families with AD HPE. Four of these had been reported previously including kindreds 2 (8, 10), 3 (10), 11 (11) , and 14 (9) . All nine were clinically reevaluated prior to molecular studies. 
RESULTS
Phenotype Analyses. We studied nine AD HPE families with three or more affected members or unaffected gene carriers in two to five generations (Fig. 1) . Eight kindreds were Caucasian, and none were related. In kindred 6, individual I.2 was Native American. The clinical manifestations in affected family members are summarized in Table 1 . Clinical reevaluation of family 11 (11) prior to the genotyping resulted in a reassignment of disease status in individual V.2 who had an HPE microform manifested by microcephaly and ocular hypotelorism. In total, we examined 125 individuals from the nine families including 20 with classical HPE and 40 with HPE microforms.
Linkage Analysis. Genetic analyses were performed in the nine families to determine whether a locus for AD HPE was linked to HPE3, one of the proposed genes mapped to 7q36 (12) . Polymorphic DNA markers from 7q36 with known map position (7cen-D7S483-D7SSSO-HPE3-D7S22-7qtel) were chosen for the linkage studies (12, 14) . The results from the linkage analyses are shown in Tables 2 and 3 . The highest logarithm of odds (lod) scores were obtained between AD HPE and D7S22 (see Table 2 ). In the reduced-penetrance analysis of the combined sample, a maximum lod score of 7.03 was obtained at a recombination distance of 0.05. There was significant heterogeneity [X2(1) = 7.60; P = 0.005] with eight families supporting linkage at 0.00 recombination and maximum lod score of 8.19. Close linkage was rejected in family 1 (see Table 3 ). In the affecteds-only model-free analysis of the combined sample, a maximum lod score of 4.81 was obtained at a recombination distance of 0.06. 
DISCUSSION
Our data show that a gene for familial HPE (AD HPE) is located in chromosome 7q36. AD HPE in eight families maps to this region with a combined lod score of 8.2 and no recombination with D7S22. Close linkage between AD HPE and DNA markers (D7S22, D7S550, or D7S483) in 7q36-was excluded in kindred 1 ( Fig. 1 and Tables 2 and 3) . These results confirm the genetic heterogeneity of familial HPE.
Clinical Manifestations in AD HPE. Clinical evaluation of individuals from the nine families confirmed the previously (Fig. 1) . The clinical manifestations, including the HPE microforms, did not differ between individuals in the unlinked kindred 1 and the other eight kindreds linked to 7q36 (Table 1) . Thus, in AD and sporadic HPE, the phenotype does not appear to differ with alterations of different putative HPE genes. AD HPE and the HPE3 Gene. On the physical map of chromosome 7q36, two of the markers used in this study (D7S22 and D7S550) flank a translocation breakpoint that probably disrupts the putative HPE gene, HPE:3. Previously, we defined the HPE minimal critical region in 7q36 (12) . Analysis of 13 HPE cell lines with overlapping deletions involving 7q36 localized D7S22 to a 5-megabase HPE critical region. A proximal deletion interval was estimated to be 1 megabase in size and contains D7S550. The two intervals are separated by the breakpoint of a cytogenetically balanced t(7;9)(q36;q34) translocation (12) that was reported in several individuals with HPE (17) . Both the physical map (12) and the linkage map from the present report suggest that the gene that is mutated in most families with AD HPE is the same gene (HPE3) that is deleted in some and rearranged in other HPE cell lines with cytogenetic anomalies in 7q36. This hypothesis can be confirmed once the putative HPE3 gene has been identified by positional cloning of candidate cDNAs from the t(7;9) translocation breakpoint. Because the one 7q36-unlinked AD HPE family is large, it may be possible to identify a second gene locus for familial HPE. Characterization of this and other HPE genes will help to elucidate the molecular basis of both normal and abnormal brain development.
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